Press Release
Aegis Sciences Corporation Acquires HealthTrackRx’s Toxicology Business Unit
FOR IMMEDIATE RELEASE: January 17, 2023
Contact:
Aneliza Jones
Vice President, Marketing & Communications
972-833-4742
[email protected]
Acquisition enhances Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing
NASHVILLE, Tenn., January 17, 2023 – Aegis Sciences Corporation, a health care testing laboratory based in Nashville, Tenn., today announced its acquisition of the HealthTrackRx Toxicology line of business.
“We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis”
Aegis has provided science-driven drug testing and consulting services since 1990. The laboratory delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens.
“Clinicians need the diagnostic ability to detect the most relevant prescribed, illicit, and synthetic drugs that directly affect patient outcomes,” said Dr. Frank Basile, Aegis Sciences Corporation CEO. “This acquisition provides the opportunity for Aegis to deliver the most comprehensive clinical toxicology testing available to more providers.”
HealthTrackRx, the nation’s premier polymerase chain reaction (RT-PCR)-based infectious disease laboratory, was founded with a focus on clinical toxicology testing. Recently, the company has transitioned its growth strategy to infectious disease testing and combating antimicrobial resistance.
“As we aggressively expand our infection detection capabilities and deliver next-morning PCR results nationwide, toxicology has become a declining portion of our clinical testing portfolio,” said Martin Price, HealthTrackRx CEO and chairman. “We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis,” Price continued.
“Aegis’s health care testing services are designed uniquely for the specialties we serve. We look forward to helping more clinicians make better decisions for their patients through our innovative approach,” said Mike Ziegler, chief commercial officer.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, Tenn., that provides science-driven testing and consulting services to health care providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information, please visit www.aegislabs.com.
About HealthTrackRx
Headquartered in Denton, TX and with facilities coast-to-coast, HealthTrackRx is the premier PCR-based infectious disease laboratory, delivering industry-leading testing turnaround times to healthcare providers nationwide. For more than 20 years, the company has enabled accurate clinical decisions through its testing platform, advancement in pathogen detection and identification, and leadership in antimicrobial stewardship. For more information, please visit healthtrackrx.com.
Contacts
Aegis:
Julia Stough
MP&F Strategic Communications
[email protected]
HealthTrackRx:
Aneliza Jones
Vice President, Marketing and Communications
972-833-4742
[email protected]
FOR IMMEDIATE RELEASE: January 17, 2023
Contact:
Aneliza Jones
Vice President, Marketing & Communications
972-833-4742
[email protected]
Acquisition enhances Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing
NASHVILLE, Tenn., January 17, 2023 – Aegis Sciences Corporation, a health care testing laboratory based in Nashville, Tenn., today announced its acquisition of the HealthTrackRx Toxicology line of business.
“We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis”
Aegis has provided science-driven drug testing and consulting services since 1990. The laboratory delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens.
“Clinicians need the diagnostic ability to detect the most relevant prescribed, illicit, and synthetic drugs that directly affect patient outcomes,” said Dr. Frank Basile, Aegis Sciences Corporation CEO. “This acquisition provides the opportunity for Aegis to deliver the most comprehensive clinical toxicology testing available to more providers.”
HealthTrackRx, the nation’s premier polymerase chain reaction (RT-PCR)-based infectious disease laboratory, was founded with a focus on clinical toxicology testing. Recently, the company has transitioned its growth strategy to infectious disease testing and combating antimicrobial resistance.
“As we aggressively expand our infection detection capabilities and deliver next-morning PCR results nationwide, toxicology has become a declining portion of our clinical testing portfolio,” said Martin Price, HealthTrackRx CEO and chairman. “We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis,” Price continued.
“Aegis’s health care testing services are designed uniquely for the specialties we serve. We look forward to helping more clinicians make better decisions for their patients through our innovative approach,” said Mike Ziegler, chief commercial officer.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, Tenn., that provides science-driven testing and consulting services to health care providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information, please visit www.aegislabs.com.
About HealthTrackRx
Headquartered in Denton, TX and with facilities coast-to-coast, HealthTrackRx is the premier PCR-based infectious disease laboratory, delivering industry-leading testing turnaround times to healthcare providers nationwide. For more than 20 years, the company has enabled accurate clinical decisions through its testing platform, advancement in pathogen detection and identification, and leadership in antimicrobial stewardship. For more information, please visit healthtrackrx.com.
Contacts
Aegis:
Julia Stough
MP&F Strategic Communications
[email protected]
HealthTrackRx:
Aneliza Jones
Vice President, Marketing and Communications
972-833-4742
[email protected]
Related Posts
FOR IMMEDIATE RELEASE: January 17, 2023
Contact:
Aneliza Jones
Vice President, Marketing & Communications
972-833-4742
[email protected]
Acquisition enhances Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing
NASHVILLE, Tenn., January 17, 2023 – Aegis Sciences Corporation, a health care testing laboratory based in Nashville, Tenn., today announced its acquisition of the HealthTrackRx Toxicology line of business.
“We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis”
Aegis has provided science-driven drug testing and consulting services since 1990. The laboratory delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens.
“Clinicians need the diagnostic ability to detect the most relevant prescribed, illicit, and synthetic drugs that directly affect patient outcomes,” said Dr. Frank Basile, Aegis Sciences Corporation CEO. “This acquisition provides the opportunity for Aegis to deliver the most comprehensive clinical toxicology testing available to more providers.”
HealthTrackRx, the nation’s premier polymerase chain reaction (RT-PCR)-based infectious disease laboratory, was founded with a focus on clinical toxicology testing. Recently, the company has transitioned its growth strategy to infectious disease testing and combating antimicrobial resistance.
“As we aggressively expand our infection detection capabilities and deliver next-morning PCR results nationwide, toxicology has become a declining portion of our clinical testing portfolio,” said Martin Price, HealthTrackRx CEO and chairman. “We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis,” Price continued.
“Aegis’s health care testing services are designed uniquely for the specialties we serve. We look forward to helping more clinicians make better decisions for their patients through our innovative approach,” said Mike Ziegler, chief commercial officer.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, Tenn., that provides science-driven testing and consulting services to health care providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information, please visit www.aegislabs.com.
About HealthTrackRx
Headquartered in Denton, TX and with facilities coast-to-coast, HealthTrackRx is the premier PCR-based infectious disease laboratory, delivering industry-leading testing turnaround times to healthcare providers nationwide. For more than 20 years, the company has enabled accurate clinical decisions through its testing platform, advancement in pathogen detection and identification, and leadership in antimicrobial stewardship. For more information, please visit healthtrackrx.com.
Contacts
Aegis:
Julia Stough
MP&F Strategic Communications
[email protected]
HealthTrackRx:
Aneliza Jones
Vice President, Marketing and Communications
972-833-4742
[email protected]
FOR IMMEDIATE RELEASE: January 17, 2023
Contact:
Aneliza Jones
Vice President, Marketing & Communications
972-833-4742
[email protected]
Acquisition enhances Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing
NASHVILLE, Tenn., January 17, 2023 – Aegis Sciences Corporation, a health care testing laboratory based in Nashville, Tenn., today announced its acquisition of the HealthTrackRx Toxicology line of business.
“We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis”
Aegis has provided science-driven drug testing and consulting services since 1990. The laboratory delivers evidence-based, clinically actionable information related to medication compliance, substance abuse, and drug-drug interactions through definitive testing of urine, oral fluid, or blood specimens.
“Clinicians need the diagnostic ability to detect the most relevant prescribed, illicit, and synthetic drugs that directly affect patient outcomes,” said Dr. Frank Basile, Aegis Sciences Corporation CEO. “This acquisition provides the opportunity for Aegis to deliver the most comprehensive clinical toxicology testing available to more providers.”
HealthTrackRx, the nation’s premier polymerase chain reaction (RT-PCR)-based infectious disease laboratory, was founded with a focus on clinical toxicology testing. Recently, the company has transitioned its growth strategy to infectious disease testing and combating antimicrobial resistance.
“As we aggressively expand our infection detection capabilities and deliver next-morning PCR results nationwide, toxicology has become a declining portion of our clinical testing portfolio,” said Martin Price, HealthTrackRx CEO and chairman. “We are grateful for the opportunity to serve our toxicology clients over the past decade and know they are in good hands with Aegis,” Price continued.
“Aegis’s health care testing services are designed uniquely for the specialties we serve. We look forward to helping more clinicians make better decisions for their patients through our innovative approach,” said Mike Ziegler, chief commercial officer.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, Tenn., that provides science-driven testing and consulting services to health care providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information, please visit www.aegislabs.com.
About HealthTrackRx
Headquartered in Denton, TX and with facilities coast-to-coast, HealthTrackRx is the premier PCR-based infectious disease laboratory, delivering industry-leading testing turnaround times to healthcare providers nationwide. For more than 20 years, the company has enabled accurate clinical decisions through its testing platform, advancement in pathogen detection and identification, and leadership in antimicrobial stewardship. For more information, please visit healthtrackrx.com.
Contacts
Aegis:
Julia Stough
MP&F Strategic Communications
[email protected]
HealthTrackRx:
Aneliza Jones
Vice President, Marketing and Communications
972-833-4742
[email protected]